Literature DB >> 4010093

Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer.

O Kojima, T Majima, Y Uehara, T Yamane, Y Fujita, T Takahashi, S Majima.   

Abstract

The present study was undertaken to determine the adenosine deaminase (ADA) activity of peripheral lymphocytes in patients with gastric cancer, with respect to the cancer progression, the effect of surgery and/or immunotherapy. The gastric cancer patients showed lower lymphocyte ADA activity than did the normal control. The lymphocyte ADA activity did not decrease with the cancer progression. There was a significant correlation between lymphocyte ADA activity and blastogenesis of lymphocyte by phytohemaglutinin or concanavalin A. Six months following gastrectomy, the lymphocyte ADA activity was increased, as compared with the preoperative value. The ADA activity of patients on post-operative OK-432 showed a greater increase, as compared to that of patients not given this treatment. In conclusion, decreased lymphocyte ADA activity in gastric cancer patients might be due to either the cancer bearing status or to the immunological suppression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010093     DOI: 10.1007/bf02469742

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Adenosine deaminase activity in patients with renal adenocarcinoma.

Authors:  G Sufrin; G L Tritsch; A Mittelman; R H Moore; G P Murphy
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

4.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

5.  Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.

Authors:  R Tung; R Silber; F Quagliata; M Conklyn; J Gottesman; R Hirschhorn
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

6.  Adenosine deaminase and purine nucleoside phosphorylase activities in lymphocytes from patients with lung cancer.

Authors:  K Ogawa; K Tominaga; S Taoka; K Yata; E Tsubura
Journal:  Gan       Date:  1978-08

7.  Further data on the adenosine deaminase (ADA) polymprphism and a report of a new phenotype.

Authors:  D A Hopkinson; P J Cook; H Harris
Journal:  Ann Hum Genet       Date:  1969-05       Impact factor: 1.670

Review 8.  Studies of lymphocyte adenosine deaminase activity in patients with renal and transitional cell carcinoma.

Authors:  G Sufrin; G L Tritsch; A Mittelman; G P Murphy
Journal:  Int Adv Surg Oncol       Date:  1978

9.  Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.

Authors:  M Russo; R Giancane; G Apice; B Galanti
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

10.  Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies.

Authors:  J Meier; M S Coleman; J J Hutton
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

  10 in total
  7 in total

1.  Association of adenosine deaminase, superoxide dismutase, and catalase activities with Helicobacter pylori.

Authors:  E Bulbuloglu; F Inanc; S Bakaris; B Kantarceken; A Cetinkaya; R Cağlar; T Kale Ilhami; M Kilinc
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues.

Authors:  A Eroglu; O Canbolat; S Demirci; H Kocaoglu; Y Eryavuz; H Akgül
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

3.  Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.

Authors:  I Durak; N Ormeci; O Akyol; O Canbolat; M Kavutçu; M Bülbül
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

4.  Serum adenosine deaminase activity in brain tumours.

Authors:  S Manjula; A Raja; S N Rao; A R Aroor; A Rao
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

5.  Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.

Authors:  Necip Pirinççi; Ilhan Geçit; Mustafa Güneş; Mehmet Bilgehan Yüksel; Mehmet Kaba; Serhat Tanık; Halit Demir; Mehmet Aslan
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

6.  Reconstruction of Tissue-Specific Metabolic Networks Using CORDA.

Authors:  André Schultz; Amina A Qutub
Journal:  PLoS Comput Biol       Date:  2016-03-04       Impact factor: 4.475

Review 7.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.